期刊文献+

泌尿生殖道感染的葡萄球菌分布及对氟喹诺酮类药物的敏感性研究 被引量:3

The Distribution of Staphylococcus Infection in Urogenital Tract and Comparative in vitro Activity of Fluoroquinolone
下载PDF
导出
摘要 目的 了解泌尿生殖道感染的葡萄球菌分布及对氟喹诺酮类药物的敏感性。 方法 选择 2 44例泌尿生殖道感染患者 ,对其葡萄球菌进行分离鉴定 ,用 6种氟喹诺酮类药物对分离到的葡萄球菌进行了敏感性试验。 结果 与泌尿生殖道感染有关的葡萄球菌分离率为 61.0 7% ,其中人葡萄球菌、金黄色葡萄球菌、溶血葡萄球菌较为常见。在 6种药物中加替沙星抗菌活性最强 ,随后依次为司帕沙星、左氧氟沙星、氧氟沙星、环丙沙星 ,诺氟沙星活性最差。 结论 人葡萄球菌、金黄色葡萄球菌、溶血葡萄球菌是泌尿生殖道感染的常见细菌 。 Objective To understand the distribution of staphylococcus in urogenty infection and staphylococcus sensitivity to fluoroquinolones. Methods Select 244 urogenty infectors,the staphylococci were cultured and identified.Minimal inhibitory concentrations(MIC)were measured by using agar dilution method. Result Among all samples,the isolation rate of staphylococcus was 60.07%,the isolation rates of staphylococcus hominis,staphylococcus aureus and staphylococcus haemolyticus were significantly higher than those of the other staphylococci.Among 6 fluoroquinolones,gatifloxacin was most active agent against staphylococci. Conclusion In urogenital tract,the infections of S.hominis,S.aureus and S.haemolyticus were more commonly seen than other staphylococci.The staphylococci have varying degree of resistance to commonly used fluoroquinolones.
出处 《实用预防医学》 CAS 2003年第6期915-917,共3页 Practical Preventive Medicine
关键词 葡萄球菌 泌尿生殖道感染 氟喹诺酮类药物 最低抑菌浓度 Staphylococcus Urogenital tract infection Fluoroquionolone Minimal inhibitory concentration
  • 相关文献

参考文献1

  • 1张致平.喹诺酮类抗菌药研究的新进展(摘要)[A]..第四届全国喹诺酮类抗菌药科研与临床应用研讨会论文汇编:2000年8月[C].北京:四川成都:中国抗生素杂志社,2000.1-20.

同被引文献18

  • 1Takahata M, Yonezawa M, Matsubara N, et al. Antibacterial activity of quinolones against coagulase-negative staphylococci and the quinolone resistance-determining region of gyrA genes from six species[J]. J Antimicrob Chemother, 1997,40:383-386.
  • 2Hooper DC. Emerging mechanism of fluoroquinolone resistance [J]. Emerg Infect Dis, 2001,7: 337-341.
  • 3Denis A, Moreau NJ. Mechanisms of quinolone resistance in clinical isolate:accumulation of sparfloxacin and of fluoroquinolones of various hydrophicity,and analysis of membrane composition[J]. J Antimicrob Chemother, 1993,32:379-392.
  • 4Takenouchi T,Tabat F, Iwata Y,et al. Hydrophilicity of quinolones is not an exclusive factor decreased activity in efflux-mediated resistant mutants of staphylococcus aureus[J]. Antimicrob Agents Chemother, 1996,40:1835-1842.
  • 5Fung-Tomc J,Minassian B,Kolek B,et al. In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin [J]. J Antimicrob Chemother, 2000, 45: 437-446.
  • 6Denis A, Moreau NJ. Mechanisms of quinolone resistance in clinical isolate: accumulation of sparfloxacin and of fluoroquilones of various hydrophicity, and analysis of membrane composition[J]. J Antimicrob Chemother, 1993,32:379-392.
  • 7Markham PN. Inhibition of the emergence of ciprofloxacin resistance in Streptococcus pneumoniae by the multidrug efflux inhibitor reserpine[J]. Antimicrob Agents Chemother, 1999,43: 988-989.
  • 8Ross JI, Eady EA, Cove JH, et al. Identification of a chromosomally encoded ABC-transport system with which the staphylococcal erythromycin exporter MsrA may interact[J]. Gene,1995,153: 93-98.
  • 9Berger JM,Gamblin SJ,Harrison SC,et al.Structure and mechanism of DNA topoisomerase Ⅱ [J ]. Nature, 1996,379(6352) :225 - 232.
  • 10Yoshida H, Bogaki M, Nakaneica M, et al. Quinolone resistance- determining region in the DNA gyrase gyrA gene of Escherichia coli[J ]. Antimicrob Agents Chemother, 1990,34(6): 1271 - 1275.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部